from 10 days after OPU onwards [3] . Based on the clinical symptoms and laboratory findings, OHSS is classified as mild, moderate, severe, or critical [4] . Hematocrit is considered the best indicator of the severity of the syndrome [5] , but leukocytosis, hypoproteinemia, and hyponatremia also associate with severe forms of OHSS [6] . Ovarian torsion and the rupture of an ovarian cyst may occur with OHSS, with symptoms of unilateral pain and anemia [7, 8] . Described risk factors for OHSS include young age, polycystic ovarian syndrome [9] , high antral follicle count and anti-Mü llerian hormone level [10] , but OHSS is still difficult to predict and prevent [11, 12] .
C-reactive protein (CRP), an acute phase protein produced by the hepatocytes, is a marker of systemic inflammation, tissue damage, and/or infection [13] . CRP measurement is of value in differential diagnosis for bacterial and viral infections and postoperative complications [14] . CRP has been suggested to exclude concomitant infection in OHSS [7] . However, the effect of OPU on CRP in high-response IVF cycles and the role of CRP in the differential diagnosis of IVF complications are unclear. The aim of this study was to assess the CRP response in conjunction with other routine laboratory parameters as an indicator of IVF complications, especially early OHSS.
Material and methods
This prospective cohort study of IVF patients was conducted at Helsinki University Hospital, Department of Obstetrics and Gynecology, Finland in 2006-08, approved by the local Ethical Committee. The study complies with the Strobe criteria [15] . Sixtyfive women with OHSS symptoms were recruited from the outpatient emergency polyclinic with informed consent. We excluded five patients with mild OHSS, as only moderate and severe forms do need special care and treatment [4, 9] . Thus we had 60 acute patients, with referral either from private clinics (68%) or from our IVF unit. Forty-seven patients had OHSS, and 13 some other IVF complication. Three patients had admissions both as early and late OHSS, resulting in 50 OHSS cases: 36 (72%) early and 14 (28%) late OHSS ( Fig. 1 ).
Data on patient characteristics, medical history, infertility treatments, and symptoms were retrieved through a structured questionnaire and medical records. The physician on duty did a gynecological and ultrasound examination, an X-ray in the case of dyspnea, and made the decisions about hospitalizing (n = 47, 78%) or discharging the patient, treatment with intravenous fluids, drainage of ascites and pleural fluid. A voluntary follow-up visit a week after discharge was offered to those hospitalized (n = 42, 89%).
OHSS was combined with another diagnosis in eight cases (four pelvic and two urinary infections, two suspected ovarian torsions). Fever (!38 8C) with intense abdominal pain was regarded as an infection. The severity of OHSS was graded by common criteria [4] and we identified the symptomatically worst day during hospitalization (dyspnea, fever, diminished diuresis, maximum waist circumference, weight, and drainage of ascites or pleural fluid).
As controls, we recruited 30 infertile women, from our IVF unit with informed consent, who had a possible risk factor (Table 1) for developing OHSS [16] when signing up for their IVF cycle or at timing of OPU. All women were treated with a standard (reduced doses) long gonadotrophin releasing hormone agonist protocol [17] , as the antagonist protocol had not yet been introduced in practice at our IVF unit. Three patients developed OHSS, resulting in 27 controls.
All blood samples were categorized as days after OPU (OPUd). Samples including serum and plasma for freezing (À80 8C) were collected from the acute patients on admission, daily or every other day on the ward, and at the follow-up visit; and from the controls prior (mid-luteal phase), repeatedly during (10th day of stimulation, OPU, OPU2, OPU7, OPU14) and after IVF cycle (OPU35).
All parameters were measured with accredited methods at the Helsinki University Hospital Laboratory (HUSLAB). For CRP particle-enhanced immunoturbidimetric assay (Tina-quant C-Reactive Protein Gen.3 1 , Roche Diagnostics, Rotkreuz, Switzerland) on a Modular Analyzer 1 (Hitachi Ltd., Tokyo, Japan) was used; detection limit 3 mg/L.
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We analyzed the data using SPSS for Windows 1 (version 18). Values above or below the detection limit were given an arbitrary value, either twice the upper detection limit or 0.5 times the lowest detection limit, respectively. Distribution of the variables was assessed by the Shapiro-Wilk test. Statistical tests between and within the groups are specified in the Tables and Figures. For correlations, we used Pearson's or Spearman's coefficient tests. Data are expressed as median; inter-quartile range (IQR) or mean AE standard deviation (SD) unless otherwise stated. The level of significance was p < 0.05.
The main outcome measure was CRP. Post hoc power analysis revealed that at OPU2 we had 93% power (1 À b) to detect the difference in the CRP levels between the controls and early OHSS when the a-level was set at 0.05. The diagnostic accuracy of CRP for early OHSS at the emergency polyclinic was analyzed by receiveroperating characteristic (ROC) curve analysis and expressed as the area under the curve (AUC).
Results
The clinical characteristics of the study groups were otherwise comparable, but patients with early OHSS were younger than the controls ( Table 1 ). All patients were generally healthy, asthma being the most common complaint (7%). A known risk factor for OHSS ( Table 1 ) was associated with early OHSS (p = 0.04 vs. late OHSS). The severe or critical forms of OHSS were more frequent with late than early OHSS (79% vs. 25%, p = 0.001). Early OHSS was characterized by a higher number of follicles and retrieved oocytes, as well as preventive procedures (more antagonist cycles, lower cumulative doses of gonadotrophins, and fewer embryo transfers) than the other groups ( Table 2) .
The symptomatically worst day on the ward with early OHSS was OPU5 (range 2-8); OPU16 (13-32) with late OHSS; and OPU2 (0-8) with other IVF complications. Eight patients were febrile, four of whom had early OHSS with infection, the rest with other IVF complications. Twelve patients received antibiotics: eight with early OHSS, one with late OHSS, and three with other IVF complications. Three patients underwent laparoscopy: one with early OHSS and ovarian torsion and two as intra-abdominal bleedings. Table 2 The treatment characteristics. The data are indicated as On admission, the CRP level was significantly higher in patients with early than late OHSS or the controls ( Table 3 ). The CRP levels did not differ between agonist and antagonist protocol treated patients (data not shown), and did not correlate with the oocyte count in early OHSS. If early OHSS was accompanied with signs of infection, the CRP was higher (55; 29-80 mg/L) than without infection (16; 6-27 mg/L, p = 0.002), similarly to other infectious IVF complications (38; 4-73 mg/L, p = 0.48). In the ROC analysis, the AUC was 0.74 (p = 0.001) with sensitivity of 69% and specificity of 71% for a cut-off CRP of 12 mg/L for early OHSS.
Control cycle
Hematocrit levels exceeded 45% in seven of 20 (35%) severe/ critical cases. Platelet count (PLC) levels were higher with late than early OHSS or other complications (Table 3) . Thrombocytosis correlated to the severity of OHSS (r = 0.31, p = 0.04). Hypoalbuminemia was worse in severe/critical OHSS (31.4; 29.6-33.3 g/L) than in moderate OHSS (36.8; 34.0-39.6 g/L, p < 0.001).
In control IVF cycles (Fig. 2 ) CRP levels increased from undetectable at mid-luteal phase to a peak of 5 (<3-9) mg/L at OPU2 (p = 0.001) followed by a decrease to 3 (<3-6) mg/L at OPU7 (p = 0.03), and to undetectable at OPU14. CRP did not correlate with BMI and the levels were similar in pregnant and non-pregnant patients (data not shown). Of the other parameters, hematocrit, white blood cell count, PLC, and albumin varied significantly, but within normal limits. CRP level at OPU, (but not at OPU2), correlated to the ovum count (r = 0.42, p = 0.03).
When analyzing CRP in the course of the disease (OPU-related data, Fig. 3 ), the CRP level in early OHSS was higher than in the controls at OPU2 (28; 10-46 mg/L, p < 0.001), and OPU7 (17; 9-25 mg/L, p = 0.001, without infection), and reached control levels at discharge (11; <3-23 mg/L). In late OHSS, the CRP level peaked to 8 (<3-18) mg/L, decreased to 6 (<3-11) mg/L at discharge, and was 7 (3-11) mg/L at the follow-up visit. Peak CRP was the highest when early OHSS was complicated with infection (108; 49-166 mg/L; without infection 20; 8-32 mg/L, p < 0.001), (Fig. 4) . BMI or the drainage of ascites (n = 23, 59%) or pleural fluid (n = 5, 13%) had no systematic effect on the CRP level. CRP levels after OPU were not affected by IVF treatment outcome (data not shown).
The mean PLC exceeded that of the controls after OPU10 in both late OHSS and in the other IVF complications groups. Plasma albumin levels at OPU7 in early OHSS were lower than in the controls (p < 0.001) and remained lower during the entire followup. The most serious hypoalbuminemia occurred in late OHSS at OPU16-21 ( Fig. 3) .
Comments
This prospective study shows that the majority of IVF complications, within a week after OPU, are associated with an elevated CRP response beyond the level induced by OPU, whereas in late OHSS, the CRP response is more stable.
To obtain reliable interpretation of CRP levels in women under IVF treatment we recruited women with clinical risk factors for OHSS. We detected that retrieval of multiple follicles and oocytes induced a peak in CRP at two days after OPU, doubling the pretreatment level. This CRP response is probably due to the tissue damage and inflammation induced by OPU, ovulation and formation of multiple corpora lutei, and is well in line with earlier studies showing a rise from the day of hCG injection to OPU [18, 19] and to the day of embryo transfer [20] . Contrary to some studies [21, 22] , we found a significant decrease, instead of an increase, in CRP from OPU2 to OPU7. As the half-life of CRP is around 19 h [13] , the decrease we found is well in line with the postoperative decline after uncomplicated abdominal surgery [14] . Probably less traumatic OPU and the use of vaginal, not intramuscular, luteal support explain the difference between the studies.
The two to three times higher CRP levels in early OHSS than in the controls, is in line with one earlier study [23] . However, distinguishing early OHSS from infective complications at the emergency polyclinic is difficult. This is also reflected in the ROC/ AUC analysis (cut-off value CRP 12 mg/L) for early OHSS, as infections usually exceed this level. Further, fever (>38 8C) has been associated with early severe OHSS in up to half of the patients [24] making the differential diagnosis of infections more complicated. Thus, the decision of antibiotic treatment requires follow-up and consideration of other risk factors for infection, such as puncture of endometriomas or tubal disease, as well as results of urine and possibly blood cultures. However, there is clinical need to search for novel biomarkers for infections [25] .
The majority of our severe cases had late OHSS with low CRP levels. The association between severity and late OHSS agrees with a previous study [26] . Another study [27] explained the severity with multiple pregnancies, which was not a factor in this study with mostly singletons. Patients with late OHSS had noticeably less clinical risk factors for OHSS than those with early OHSS, in line with an earlier study [26] , further emphasizing the distinct nature of these two forms of OHSS.
In our series, one patient had early OHSS with a rising CRP level from 100 to 150 mg/L (OPU2-4), but no signs of clinical infection or other complications. She had an uneventful surveillance without antibiotics. Another patient with previous mild asthma was treated on the internal medicine ward as pneumonia due to severe breathing difficulties and pleural fluid before diagnosing late OHSS, highlighting the accurate diagnostics and knowledge of OHSS symptoms in emergency polyclinics.
Hemoconcentration (hematocrit !45%) as a traditional marker of severe OHSS is arguable as only one third of our patients met this [ ( F i g . _ 2 ) T D $ F I G ] criterion on admission. This is probably due to the current recommendation to take care of fluid balance during IVF treatment, especially with OHSS symptoms. To our knowledge, only little is known about platelet levels during OHSS or the IVF cycle, although platelets are known to have a role in corpus luteum formation [28] . Our finding of elevated PLC levels from 10 days to over a month after OPU, especially in late OHSS, and the association of PLC level and the severity of the syndrome may relate to inflammatory, interleukin-6 induced PLC formation from bone marrow [29] , as elevated interleukin-6 levels have been detected in OHSS [30] . However, thrombocytosis as a marker of hemoconcentration [7] was not supported, as hemodilution and thrombocytosis occurred simultaneously in patients with late OHSS.
A limitation of our study is the small number of IVF complications other than OHSS to evaluate the differences in laboratory parameters in those. It can also be argued that we miss data on the anti-Mü llerian hormone in risk factor assessment for OHSS, as it was not in general use at that time. Additionally, the control IVF cycles give no data from antagonist cycles and agonist triggering, a current method used to prevent imminent OHSS [31, 32] . However, we think, that the reduced dose agonist cycles show us the best reference levels for emergency polyclinics, as antagonist cycles are supposed to induce less systemic inflammation [19, 33] . Further, we could compare most samples of acute patients to the controls after OPU up to OPU14 and at OPU35. To our knowledge, comparisons with this extent have not been reported. We also reached all the most severe IVF complications of the area at our tertiary clinic.
IVF complications offer a diagnostic challenge to the clinician on duty. Knowledge of the day of admission according to OPU and the progress of the preceding IVF protocol is of utmost importance for interpreting laboratory results when evaluating possible IVF complications. Caution is also needed in the interpretation of CRP level with obesity and pregnancy, as these conditions have been associated with elevated levels of inflammatory markers [34] [35] [36] . However, the possibility of OHSS, early or late, should always be considered.
In conclusion, without other signs of infection, elevated CRP indicates follow-up, but is not an indication to prescribe antibiotics. We suggest that, a clinically elevated CRP level (>10 mg/L) in the first week after OPU is indicative for early OHSS and/or infection in IVF patients, whereas later, increased platelet count and hypoalbuminemia in patients with embryo transfer, support the diagnosis of late OHSS. Any of these findings, with or without hemoconcentration, indicates follow-up.
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